Ledger.Open graph →
SEC Form D · filed September 11, 2015

CORTEX PHARMACEUTICALS INC/DE/

Offering
$3.0M
Sold
$721K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GLEN ROCK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Robert N. Weingarten · Glen Rock, NJExec · DirectorJames E. Sapirstein · Glen Rock, NJDirectorKathryn E. Macfarlane · Glen Rock, NJDirectorRichard E. Purcell · Glen Rock, NJExecArnold S. Lippa · Glen Rock, NJExec · DirectorJeff E. Margolis · Glen Rock, NJExec · DirectorJames S. Manuso · Glen Rock, NJExec · DirectorPhilip W. Treick · San Francisco, CADirectorGary W. Bender · Scottsdale, AZExecRobert W. Mullin · San Francisco, CAExec · DirectorJames R. Keller · San Francisco, CADirectorKarl Loevenich · Bradenton, FLExec · DirectorChristine Day · Vancouver, British Columbia, CanadaDirectorNicole Agnew · Vancouver, British Columbia, CanadaExec · DirectorJeff E. Margolis · Glen Rock, NJExec · DirectorJames S. Manuso · Dublin, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗